Primary Care and PCNs

Applied filters

Primary Care and PCNs

Care Setting (66)
- Adults (7)
- Care homes (10)
- Care of the elderly (1)
- Community Health Services (17)
- Dentistry (3)
- Health and Justice (14)
- Neonates (1)
- Occupational Health (3)
- Paediatrics (3)
- Palliative and End of Life Care (4)
- Primary Care and PCNs (66)
- Transfer of care (9)
- Trusts (17)
Events (16)
- Past Events (16)
Guidance (44)
- Adherence (1)
- Administering (8)
- Adverse effects (3)
- Cautions and contraindications (1)
- Complementary medicines (3)
- Dosing (1)
- Formulation (1)
- Implementation (2)
- Interactions (3)
- Medication Safety (3)
- Patient Group Directions (13)
- Poisoning (1)
- Policy, Commissioning and Managerial (3)
- Prescribing (2)
- Safety in Breastfeeding (1)
- Safety in Pregnancy (1)
- Service advice and planning (5)
- Supply (7)
- Swallowing difficulties (3)
- Switching (4)
- Temperature management (1)
  - Cold chain management (1)
- Unlicensed medicines (1)
Medicine (14)
- Adrenaline (2)
- Agomelatine (1)
- Alendronic acid (1)
- Amantadine (1)
- Amitriptyline (1)
- Amoxicillin (1)
- Articaine + Adrenaline (1)
- Atorvastatin (1)
- Beclometasone (1)
- Beclometasone + Formoterol (1)
- Bromocriptine (1)
- Budesonide (1)
- Budesonide + Formoterol (1)
- Buprenorphine (1)
- COVID-19 vaccine (1)
- Cabergoline (1)
- Carbamazepine (2)
- Carbidopa + Levodopa + Entacapone (2)
- Cholesterol + Simvastatin (1)
- Ciclosporin (1)
- Citalopram (1)
- Clozapine (1)
- Co-beneldopa (1)
- Co-careldopa (1)
- Diltiazem (1)
- Doxazosin (1)
- Doxepin (1)
- Duloxetine (1)
- Entacapone (1)
- Escitalopram (1)
- Fentanyl (1)
- Fluoxetine (1)
- Fluticasone (1)
- Fluticasone + Formoterol (1)
- Fluticasone + Salmeterol (1)
- Fluvastatin (1)
- Fluvoxamine (1)
- Ibandronic acid (1)
- Imipramine (1)
- Influenza vaccine (1)
- Isocarboxazid (1)
- Levodopa (1)
- Levodopa + Carbidopa + Entacapone (2)
- Levothyroxine (1)
- Lidocaine (1)
- Lidocaine + Adrenaline (1)
- Lidocaine + Prilocaine (1)
- Lithium (1)
- Lithium carbonate (1)
- Lofepramine (1)
- Lovastatin (1)
- Mepivacaine (1)
- Mepivacaine + Adrenaline (1)
- Mesalazine (1)
- Methotrexate (2)
- Methylphenidate (1)
- Mianserin (1)
- Mirtazapine (1)
- Moclobemide (1)
- Morphine (1)
- Mycophenolate mofetil (1)
- Nifedipine (1)
- Nortriptyline (1)
- Oseltamivir (1)
- Oxycodone (1)
- Paroxetine (1)
- Pergolide (1)
- Phenelzine (1)
- Phenobarbital (1)
- Phenoxymethylpenicillin (1)
- Phenytoin (2)
- Pramipexole (1)
- Pravastatin (1)
- Prilocaine (1)
- Prilocaine + Felypressin (1)
- Primidone (1)
- Rasagiline (1)
- Reboxetine (1)
- Risedronate sodium (1)
- Ropinirole (1)
- Rosuvastatin (1)
- Rotigotine (1)
- Selegiline (2)
- Sertraline (1)
- Simvastatin (1)
- Sodium valproate (1)
- Tacrolimus (1)
- Tiotropium (1)
- Tolcapone (1)
- Tramadol (1)
- Tranylcypromine (1)
- Trimipramine (1)
- Venlafaxine (1)
- Vortioxetine (1)
- Warfarin (1)
Medicines planning (4)
- Patient Group Direction Planning (4)
Publications (3)
- Research and audits (1)
- Summary advice (1)
- Templates (1)
Specialty (20)
- Cardiovascular system disorders (4)
- Diabetes (2)
- Endocrine system disorders (1)
- Infection and infectious diseases (1)
- Learning disabilities (1)
- Mental health and illness (4)
- Neurological disorders (4)
- Renal and urologic disorders (1)
- Reproductive health (2)
- Travel Medicine (1)
- Vaccinating (2)
Training and Development (13)

Non-acute settings with healthcare input and transcribing

22 February 2022Consideration needs to be given to the risk factors particularly associated with transcribing in non-acute settings with healthcare input

Risk assessing transcribing for administration

22 February 2022Various factors affect the risks associated with using transcribing for medicines administration.

Alternatives to transcribing for medicines administration

22 February 2022Transcribing is not the preferred option for medicines administration and the alternatives should be considered before committing to transcribing.

Understanding transcribing for medicines administration

22 February 2022Transcribing for medicines administration in healthcare requires assessment and mitigation against identified risks. These risks vary according to setting.

Using coenzyme Q10 supplements for statin-induced muscle symptoms

18 February 2022People often buy coenzyme Q10 supplements to help with statin-induced muscle symptoms. However, there is insufficient evidence to recommend its use.

Liquid Medicines Standardisation for Children

20 January 2022An ‘On the Couch’ discussion between specialist pharmacists in challenging discussions on liquid medicines standardisation for children.

Avoid prescribing desiccated (natural) thyroid extract

20 January 2022Levothyroxine is the standard of care for treating hypothyroidism. Desiccated or natural thyroid extracts (DTE) are not routinely recommended.

Primary Care Discussions: End of Life care

9 December 2021Challenging discussions on end of life care - an 'On the Couch' discussion between specialist pharmacists and those working in primary care

Supporting colleagues in managing complexity and challenge

25 November 2021An ‘On the Couch’ discussion on how to practically support colleagues in managing complexity and challenge in general practice.

Nursing Associates, Physician Associates and the use of PGDs

16 November 2021A summary is provided on the legal position on the use of Patient Group Directions by Nursing Associates and Physician Associates

SPS - Specialist Pharmacy Service

NHS